AstraZeneca Sues Andrx Over Tropol-XL Patent

Law360, New York (February 5, 2004, 12:00 AM EST) -- AstraZeneca has filed a lawsuit in the U.S. District Court for the District of Delaware against Andrx for patent infringement over the generic drug maker’s plans to make a generic version of hypertension drug Troprol-XL.

The U.K.-Swedish drug maker said it filed the suit after Andrx submitted a Paragraph IV Certification letter letter indicating its intention to manufacture and sell metoprolol succinate in the 50 mg dose form in the U.S.

Metoprolol succinate is marketed as Toprol-XL in the United States by AstraZeneca. In 2003, TOPROL-XL...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.